We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CFXA market cap is 9.7B. The company's latest EPS is USD -0.6092 and P/E is -85.59.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 383.81M | 445.42M | 406.15M | 428.5M | 417.52M |
Operating Income | -16.94M | 3.27M | -24.97M | -14.49M | -20.49M |
Net Income | -66.61M | -38.6M | -23.35M | -10M | -2.88M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 3.33B | 3.07B | 3.85B | 1.6B | 1.71B |
Operating Income | 207.81M | 165.79M | 256.42M | -71.78M | -68.41M |
Net Income | -527.65M | 42.63M | 72.14M | -13.29M | -33.26M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 4.44B | 4.27B | 4.3B | 4.44B | 4.4B |
Total Liabilities | 1.04B | 823.45M | 854.32M | 992.79M | 959.19M |
Total Equity | 3.41B | 3.45B | 3.45B | 3.45B | 3.44B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 7.39B | 7.35B | 8.52B | 4.27B | 4.51B |
Total Liabilities | 3.9B | 3.76B | 3.85B | 823.45M | 1.09B |
Total Equity | 3.49B | 3.59B | 4.66B | 3.45B | 3.42B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -19.9M | -55.86M | 7.46M | 35.56M | 66.57M |
Investing | -139.31M | -176.39M | -34.39M | -165.99M | -183.1M |
Financing | -506.76M | -465.13M | 24.5M | 138.71M | 125.01M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 130.95M | 301.94M | 356.1M | -55.86M | 134.99M |
Investing | -1.63B | -175.08M | -320.48M | -176.39M | -242.47M |
Financing | 1.37B | -131.65M | 584.91M | -465.13M | 127.8M |
Market Cap | 9.7B |
Price to Earnings Ratio | -85.59 |
Price to Sales Ratio | 1.67 |
Price to Cash Ratio | 78.65 |
Price to Book Ratio | 0.83 |
Dividend Yield | - |
Shares Outstanding | 54.59M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 9.9 (5.24%) |
Company Name | Colfax Corporation |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.enovis.com |
Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions